[1]. Luecking, et al. Identification of potent and highly selective PTEFb inhibitor BAY 1251152 for the treatment of cancer: from p.o. to i.v. application via scaffold hops. AACR; Cancer Res 2017;77(13 Suppl):Abstract nr 984. doi:10.1158/1538-7445.AM2017-984 https://aacrjournals.org/cancerres/article/77/13_Supplement/984/622158/Abstract-984-Identification-of-potent-and-highly [2]. WO 2014076091 A1
合成参考文献
参考文献:10.1021/acs.jmedchem.1c02064 摘要:Shi Z, Tian L, Qiang T, Li J, Xing Y, Ren X, Liu C, Liang C. From Structure Modification to Drug Launch: A Systematic Review of the Ongoing Development of Cyclin-Dependent Kinase Inhibitors for Multiple Cancer Therapy. J Med Chem. 2022 May 12;65(9):6390–418. doi: 10.1021/acs.jmedchem.1c02064.